1 Corporate Drive
South San Francisco, CA 94080


Group 295 1

Meet Soley

Illuminating Cellular Language to Revolutionize Drug Discovery & Development

Our Mission

To apply Cellular Language to revolutionize drug discovery & development to benefit the lives of patients.

Group 297

Our Values

Focusing on the best interests of the patients


Honesty and integrity in all that we do.


Scientific rigor and continuous innovation.


Create benefits for patients in need.


An attractive work environment that stimulates and rewards collegiality, creativity, and disciplined productivity.


Business principles and practices that prioritize accessibility to our drugs.

Our Team

What started as the brainchild of a cardiologist and a cancer biologist has grown into a team of more than two dozen experts from across the medical, pharmaceutical, and scientific industries.

Our Origin Story

Cardiologist Yerem Yeghiazarians, MD, and cancer biologist Kurosh Ameri, PhD founded Soley Therapeutics in 2020 after working together at UCSF for more than a decade to answer the question, “How do cells determine their fate?” 


Join our team of scientists, high-throughput screening automation experts, security and IT specialists, and AI/ML engineers who are catalyzing the next wave of drug discovery and development.

Sheila Gujrathi, M.D.

Dan Von Hoff, M.D.

Afsaneh Naimollah

Leo Grady, PhD

Fei-Fei Li, PhD

Peter Libby, MD

Keith Flaherty, MD

Clay Johnston, MD, PhD

Tony Adamis, MD

Antoine Yver, MD

Dan Von Hoff, MD

Co-Founder, CEO, Board Member